- Home
- CCIF vs CNTB Comparison
CCIF vs CNTB Comparison
Compare CCIF & CNTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCIF
- CNTB
- Stock Information
- Founded
- CCIF 2011
- CNTB 2012
- Country
- CCIF United States
- CNTB United States
- Employees
- CCIF N/A
- CNTB N/A
- Industry
- CCIF Finance/Investors Services
- CNTB Biotechnology: Pharmaceutical Preparations
- Sector
- CCIF Finance
- CNTB Health Care
- Exchange
- CCIF Nasdaq
- CNTB Nasdaq
- Market Cap
- CCIF 111.5M
- CNTB 94.2M
- IPO Year
- CCIF N/A
- CNTB 2021
- Fundamental
- Price
- CCIF $5.28
- CNTB $1.65
- Analyst Decision
- CCIF
- CNTB Strong Buy
- Analyst Count
- CCIF 0
- CNTB 2
- Target Price
- CCIF N/A
- CNTB $7.50
- AVG Volume (30 Days)
- CCIF 76.9K
- CNTB 75.7K
- Earning Date
- CCIF 01-01-0001
- CNTB 11-30-2025
- Dividend Yield
- CCIF 25.90%
- CNTB N/A
- EPS Growth
- CCIF N/A
- CNTB N/A
- EPS
- CCIF N/A
- CNTB N/A
- Revenue
- CCIF N/A
- CNTB $1,965,000.00
- Revenue This Year
- CCIF N/A
- CNTB N/A
- Revenue Next Year
- CCIF N/A
- CNTB $453,067.90
- P/E Ratio
- CCIF N/A
- CNTB N/A
- Revenue Growth
- CCIF N/A
- CNTB N/A
- 52 Week Low
- CCIF $7.43
- CNTB $1.23
- 52 Week High
- CCIF $10.16
- CNTB $2.20
- Technical
- Relative Strength Index (RSI)
- CCIF 40.39
- CNTB 48.99
- Support Level
- CCIF $5.17
- CNTB $1.46
- Resistance Level
- CCIF $5.29
- CNTB $1.72
- Average True Range (ATR)
- CCIF 0.13
- CNTB 0.13
- MACD
- CCIF 0.00
- CNTB -0.02
- Stochastic Oscillator
- CCIF 31.22
- CNTB 43.18
About CCIF Carlyle Credit Income Fund Shares of Beneficial Interest
Carlyle Credit Income Fund is a non-diversified, closed-end management investment company. The Fund's primary investment objective is to generate current income, with a secondary objective to generate capital appreciation. The Fund seeks to achieve its investment objective by investing predominantly in equity and junior debt tranches of collateralized loan obligations, that are collateralized by a portfolio consisting mainly of below-investment-grade U.S. senior secured loans with a large number of distinct underlying borrowers across various industry sectors.
About CNTB Connect Biopharma Holdings Limited
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.